Finance

Beta
Lists
BIOV:CNSX
Biovaxys Technology Corp
CA$0.070
0.00%
(0.00) 1D
May 5, 3:55:53 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Mkt. cap
3.09M
Avg. vol.
32.47K
Volume
0.00
52-wk high
CA$0.40
52-wk low
CA$0.03
EPS
-CA$0.23
Mkt. cap
3.09M
Avg. vol.
32.47K
Volume
0.00
52-wk high
CA$0.40
52-wk low
CA$0.03
EPS
-CA$0.23
News stories
From sources across the web
About Biovaxys Technology Corp
CEO-
Employees-
Founded-
HeadquartersToronto, Ontario, Canada
SectorPharmaceutical industry
Websitebiovaxys.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.50K
32.95K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.20M
1.03M
1.08M
859.08K
Operating expense
1.49M
1.14M
1.22M
859.08K
Total operating expenses
1.49M
1.14M
1.22M
859.08K
Operating income
-1.49M
-1.14M
-1.22M
-859.08K
Other non operating income
-8.90K
-68.18K
-67.98K
-50.97K
EBT including unusual items
-2.74M
-1.07M
-1.32M
-910.06K
EBT excluding unusual items
-1.50M
-1.25M
-1.30M
-910.06K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.74M
-1.07M
-1.32M
-910.06K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer